about   CII home   shop   checkout


 

PEGS-podcast-Novobrantseva

 
 
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.
 

Related Events